Home > Insider Trading > Filing (0001209191-19-055034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673772	Rapt Therapeutics Inc.	RAPT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1646110	Russell Brian Wong	C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-04	25,000	$0.00	355,000	No	4	C	Indirect	By The Wong Family Trust Dated February 4, 2008
Common Stock	Acquisiton	2019-11-04	25,000	$12.00	125,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By The Wong Family Trust Dated February 4, 2008
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2019-11-04	150,000	$0.00	25,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

At the closing of the Issuer's initial public offering, each share of Series B Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series B Preferred Stock have no expiration date.
The shares are held directly by The Wong Family Trust Dated February 4, 2008 for which the Reporting Person is a trustee.